Aurinia Pharmaceuticals Inc (AUP.TO)
AUP.TO on Toronto Stock Exchange
7.85CAD
16 Aug 2019
7.85CAD
16 Aug 2019
Change (% chg)
$0.35 (+4.67%)
$0.35 (+4.67%)
Prev Close
$7.50
$7.50
Open
$7.55
$7.55
Day's High
$7.88
$7.88
Day's Low
$7.50
$7.50
Volume
28,243
28,243
Avg. Vol
38,743
38,743
52-wk High
$10.47
$10.47
52-wk Low
$6.61
$6.61
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Mar '19 | 0.03 | -0.138 |
| FY 2018 | Dec '18 | 0.03 | -0.171 |
| Sep '18 | 0.38 | -0.215 | |
| Jun '18 | 0.03 | -0.186 | |
| Mar '18 | 0.03 | -0.184 | |
| FY 2017 | Dec '17 | 0.03 | -0.040 |
| Sep '17 | 0.03 | -0.157 | |
| Jun '17 | 0.33 | -0.029 | |
| Mar '17 | 0.03 | -0.916 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-19 | 2 | 0.07 | 0.10 | 0.03 | -- |
| Quarter Ending Dec-19 | 2 | 0.07 | 0.10 | 0.03 | -- |
| Year Ending Dec-19 | 2 | 0.21 | 0.30 | 0.12 | 0.15 |
| Year Ending Dec-20 | 2 | 19.66 | 39.12 | 0.20 | 39.06 |
| Earnings (per share) | |||||
| Quarter Ending Sep-19 | 2 | -0.15 | -0.10 | -0.20 | -- |
| Quarter Ending Dec-19 | 2 | -0.17 | -0.11 | -0.24 | -- |
| Year Ending Dec-19 | 3 | -0.64 | -0.45 | -0.75 | -0.63 |
| Year Ending Dec-20 | 3 | -0.26 | 0.06 | -0.53 | -0.12 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 98.31 | 33.85 | |
| P/E High - Last 5 Yrs. | -- | 169.52 | 54.29 | |
| P/E Low - Last 5 Yrs. | -- | 53.54 | 28.22 | |
| Beta | 1.38 | 1.29 | 0.99 | |
| Price to Sales (TTM) | 1,225.29 | 42.65 | 7.90 | |
| Price to Book (MRQ) | 4.07 | 12.25 | 4.38 | |
| Price to Tangible Book (MRQ) | 4.46 | 17.14 | 5.07 | |
| Price to Cash Flow (TTM) | -- | 64.56 | 23.70 | |
| % Owned Institutions | -- | 3.24 | 1.78 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.11 | 1.67 | |
| Dividend Yield - 5 Year Avg | -- | 0.05 | 1.37 | |
| Dividend 5 Year Growth Rate | -- | 0.86 | 6.82 | |
| Payout Ratio(TTM) | -- | 2.55 | 46.67 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 0.00 | 53.93 | 14.65 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 10.50 | 51.52 | 8.45 | |
| Sales - 5 Yr. Growth Rate | -13.73 | 33.42 | 9.43 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 25.13 | -8.31 | 19.40 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -73.33 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 22.74 | 7.15 | |
| Capital Spending - 5 Yr. Growth Rate | -7.03 | 26.66 | 8.01 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.76 | 2.52 |
| Current Ratio (MRQ) | 23.31 | 3.87 | 3.52 |
| LT Debt to Equity (MRQ) | 0.23 | 7.63 | 12.61 |
| Total Debt to Equity (MRQ) | 0.30 | 20.26 | 17.64 |
| Interest Coverage (TTM) | -- | 30.21 | 14.93 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 21.69 | 50.25 | |
| Gross Margin - 5 Yr. Avg. | -- | 58.96 | 51.36 | |
| EBITD Margin (TTM) | -12,221.81 | -- | -- | |
| EBITD - 5 Yr. Avg | -10,396.69 | -12.49 | 16.42 | |
| Operating Margin (TTM) | -12,556.37 | -124.67 | -6.97 | |
| Operating Margin - 5 Yr. Avg. | -10,931.68 | -28.74 | 11.87 | |
| Pre-Tax Margin (TTM) | -13,171.49 | -126.48 | -7.30 | |
| Pre-Tax Margin - 5 Yr. Avg. | -12,502.36 | -34.06 | 15.72 | |
| Net Profit Margin (TTM) | -13,190.06 | -132.21 | -11.11 | |
| Net Profit Margin - 5 Yr. Avg. | -12,507.01 | -38.92 | 11.11 | |
| Effective Tax Rate (TTM) | -- | 17.21 | 20.61 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.84 | 24.51 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 15,624 | 10,400,894 | 870,638,159 | |
| Net Income/Employee (TTM) | -2,060,878 | 2,349,448 | 101,855,832 | |
| Receivable Turnover (TTM) | 1.54 | 12.32 | 5.88 | |
| Inventory Turnover (TTM) | -- | 2.26 | 3.66 | |
| Asset Turnover (TTM) | 0.00 | 0.32 | 0.85 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -35.83 | 6.26 | 10.25 | |
| Return on Assets - 5 Yr. Avg. | -47.02 | 6.14 | 11.17 | |
| Return on Investment (TTM) | -37.11 | 7.52 | 12.69 | |
| Return on Investment - 5 Yr. Avg. | -50.56 | 7.98 | 14.15 | |
| Return on Equity (TTM) | -41.86 | 7.94 | 17.13 | |
| Return on Equity - 5 Yr. Avg. | -61.62 | 8.90 | 15.53 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 10.24 | 25.36 | -13.73 |
| EPS (TTM) % | 17.83 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Aurinia Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -5.32 | -6.18 | 86 | 4 |
| 13 Week | -3.20 | -2.71 | 99 | 7 |
| 26 Week | 0.86 | -6.24 | 99 | 20 |
| 52 Week | 8.49 | 7.99 | 99 | 12 |
| YTD | -11.85 | -23.63 | 74 | 9 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 32.97% |
| # of Holders: | 103 |
| Total Shares Held: | 30,215,724 |
| 3 Mo. Net Change: | -44,064 |
| # New Positions: | 2 |
| # Closed Positions: | 2 |
| # Increased Positions: | 8 |
| # Reduced Positions: | 5 |
| # Net Buyers: | 3 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.